Prensa

Cobertura de prensa

Titulares sobre las empresas que clasificamos, recopilados de fuentes de noticias públicas. Enlazamos al artículo original y no lo republicamos — las etiquetas de sentimiento se basan en palabras clave, no en juicio editorial.

Mostrando cobertura para Evolus

27 titulares · 1,721 empresas cubiertas

1–27 de 27

2026-10-18
Bronstein, Gewirtz & Grossman, LLC Encourages Evolus, Inc. (EOLS) - The National Law Review
Evolus· natlawreview.com
2026-10-15
Evolus Enters Hair Restoration Market With Potential First-in-class Injectable - The Dermatology Digest
Evolus· thedermdigest.com
2026-10-15
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Evolus, Inc. - EOLS - PR Newswire
Evolus· www.prnewswire.com
2026-10-15
Evolus, Inc. (EOLS) stock price, news, quote and history - Yahoo Finance Australia
Evolus· au.finance.yahoo.com
2026-10-14
Evolus Expands Into Injectable Hair Restoration - Orange County Business Journal
Evolus· www.ocbj.com
2026-10-14
Evolus enters option deal for hair restoration treatment - Investing.com
Evolus· www.investing.com
2026-10-14
Evolus Expands Innovation Pipeline with Novel Injectable Hair Restoration Program
Evolus· finance.yahoo.com
2026-10-12
EOLS Investors with $100,000 in Losses Have Opportunity to Join Evolus, Inc. Fraud Investigation with SBS Law - Business Wire
Evolus· www.businesswire.com
2026-10-08
UTMD Trades at a Premium to the Industry: How to Play the Stock?
Evolus· finance.yahoo.com
2026-10-05
FDA dings Evolus for blurring the lines between Botox rival and lipstick - Fierce Pharma
Evolus· www.fiercepharma.com
2026-10-02
FDA Flags Evolus’ Jeuveau Instagram Promotion As Misleading, Seeks Corrective Action
Evolus· stocktwits.com
2026-10-01
Evolus Launches Wings by Evolus, a New Charitable Platform to Mobilize Its Community in Support of Important Causes
Evolus· finance.yahoo.com
2026-09-09
Evolus (EOLS) Notches A Profit Milestone While Betting Big On The Future
Evolus· finance.yahoo.com
2026-09-01
A Wave of Weight-Loss Drugs Is Quietly Creating a Multi-Billion-Dollar Opportunity That Aesthetic Medicine Is Racing to Capture
Evolus· finance.yahoo.com
2026-08-31
Telix Appoints David Gill as Chair
Evolus· finance.yahoo.com
2026-08-27
Wall Street Analysts Think Evolus (EOLS) Could Surge 77.68%: Read This Before Placing a Bet
Evolus· finance.yahoo.com
2026-08-17
Following Heightened Competition from Botox, Xeomin, and Long-Acting Daxxify, New Study Evaluates Dysport (abobotulinumtoxinA) Revenue Trajectory Through 2034
Evolus· finance.yahoo.com
2026-08-11
Wall Street Analysts Believe Evolus (EOLS) Could Rally 106.08%: Here's is How to Trade
Evolus· finance.yahoo.com
2026-08-06
Evolus Inc (EOLS) (Q2 2026) Earnings Call Highlights: Revenue Surges 21% and Adjusted EBITDA ...
Evolus· finance.yahoo.com
2026-08-06
Evolus Q2 Earnings Call Highlights
Evolus· marketbeat.com
2026-08-06
Evolus, Inc. (EOLS) Reports Break-Even Earnings for Q2
Evolus· finance.yahoo.com
2026-08-05
Evolus Reports Strong Second Quarter 2026 Financial Results; Delivers Third Consecutive Quarter of Positive Adjusted EBITDA and Raises Full-Year 2026 Financial Outlook
Evolus· finance.yahoo.com
2026-08-04
Evolus Expands Strategic Partnership with Symatese to Commercialize Estyme® in Canada, Australia, and New Zealand
Evolus· finance.yahoo.com
2026-07-28
Jushi Holdings Inc. (JUSHF) Reports Q2 Loss, Tops Revenue Estimates
Evolus· finance.yahoo.com
2026-07-22
Evolus to Report Second Quarter Financial Results on August 5, 2026
Evolus· finance.yahoo.com
2026-07-10
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Evolus· finance.yahoo.com
2026-07-08
Evolus Announces Partnership with IBSA to Develop and Commercialize Market-Leading Profhilo® in the United States, Expanding Its Injectable Portfolio into Skin Quality
Evolus· finance.yahoo.com